Vitalhub Beheer

Beheer criteriumcontroles 3/4

De CEO Vitalhub is Dan Matlow, benoemd in Nov2016, heeft een ambtstermijn van 8.17 jaar. De totale jaarlijkse vergoeding van { bedraagt CA$ 836.36K, bestaande uit 49.6% salaris en 50.4% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 1.68% van de aandelen van het bedrijf, ter waarde CA$ 9.88M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 8 jaar en 8.2 jaar.

Belangrijke informatie

Dan Matlow

Algemeen directeur

CA$836.4k

Totale compensatie

Percentage CEO-salaris	49.6%
Dienstverband CEO	8.2yrs
Eigendom CEO	1.7%
Management gemiddelde ambtstermijn	8yrs
Gemiddelde ambtstermijn bestuur	8.2yrs

Recente managementupdates

Recent updates

Vitalhub's (TSE:VHI) Performance Is Even Better Than Its Earnings Suggest

Aug 15

Vitalhub Corp. (TSE:VHI) Soars 25% But It's A Story Of Risk Vs Reward

Aug 11

After Leaping 27% Vitalhub Corp. (TSE:VHI) Shares Are Not Flying Under The Radar

Feb 06

If EPS Growth Is Important To You, Vitalhub (TSE:VHI) Presents An Opportunity

Jan 27

Vitalhub Corp.'s (TSE:VHI) P/E Is Still On The Mark Following 40% Share Price Bounce

Nov 24

Shareholders Will Be Pleased With The Quality of Vitalhub's (TSE:VHI) Earnings

Nov 16

Is Vitalhub (TSE:VHI) A Risky Investment?

Dec 22

Brokers Are Upgrading Their Views On Vitalhub Corp. (TSE:VHI) With These New Forecasts

Apr 28

Are Investors Undervaluing Vitalhub Corp. (CVE:VHI) By 40%?

Aug 24

Here's Why Shareholders May Want To Be Cautious With Increasing Vitalhub Corp.'s (CVE:VHI) CEO Pay Packet

Jun 29

Vitalhub Corp.'s (CVE:VHI) Intrinsic Value Is Potentially 48% Above Its Share Price

May 18

Is Vitalhub Corp. (CVE:VHI) Potentially Undervalued?

Apr 01

Loss-Making Vitalhub Corp. (CVE:VHI) Set To Breakeven

Feb 16

Does Vitalhub's (CVE:VHI) Share Price Gain of 49% Match Its Business Performance?

Dec 24

An Intrinsic Calculation For Vitalhub Corp. (CVE:VHI) Suggests It's 40% Undervalued

Nov 19

Analyse CEO-vergoeding

Hoe is Dan Matlow's beloning veranderd ten opzichte van Vitalhub's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Sep 30 2024	n/a	n/a	CA$3m
Jun 30 2024	n/a	n/a	CA$5m
Mar 31 2024	n/a	n/a	CA$6m
Dec 31 2023	CA$836k	CA$415k	CA$5m
Sep 30 2023	n/a	n/a	CA$3m
Jun 30 2023	n/a	n/a	CA$486k
Mar 31 2023	n/a	n/a	-CA$61k
Dec 31 2022	CA$461k	CA$310k	CA$1m
Sep 30 2022	n/a	n/a	CA$947k
Jun 30 2022	n/a	n/a	CA$331k
Mar 31 2022	n/a	n/a	-CA$267k
Dec 31 2021	CA$629k	CA$275k	-CA$2m
Sep 30 2021	n/a	n/a	-CA$2m
Jun 30 2021	n/a	n/a	-CA$3m
Mar 31 2021	n/a	n/a	-CA$2m
Dec 31 2020	CA$519k	CA$240k	-CA$2m
Sep 30 2020	n/a	n/a	-CA$1m
Jun 30 2020	n/a	n/a	-CA$860k
Mar 31 2020	n/a	n/a	-CA$1m
Dec 31 2019	CA$392k	CA$240k	-CA$626k
Sep 30 2019	n/a	n/a	-CA$738k
Jun 30 2019	n/a	n/a	-CA$556k
Mar 31 2019	n/a	n/a	-CA$807k
Dec 31 2018	CA$281k	CA$240k	-CA$862k

Compensatie versus markt: De totale vergoeding ($USD 580.76K ) Dan } ligt onder het gemiddelde voor bedrijven van vergelijkbare omvang in de Canadian markt ($USD 1.15M ).

Compensatie versus inkomsten: De beloning van Dan is het afgelopen jaar met meer dan 20% gestegen, terwijl de winst van het bedrijf met meer dan 20% is gedaald.

CEO

Dan Matlow (61 yo)

8.2yrs

Tenure

CA$836,360

Compensatie

Mr. Daniel Matlow, also known as Dan, served as Independent Director of Danavation Technologies Inc. until July 11, 2022 and has served as its Director since February 12, 2021. He has been the President an...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Daniel Matlow	President	8.2yrs	CA$836.36k	1.68% CA$ 9.9m
Brian Goffenberg	CFO & Executive VP	8.2yrs	CA$438.17k	1.58% CA$ 9.3m
Patrick Mazza	Chief Operating Officer	3yrs	CA$360.53k	0.078% CA$ 462.2k
Lisa Riley	Deputy CEO and VP of Strategy & Sales	no data	CA$281.04k	geen gegevens
Mike Sanders	CEO of VitalHub UK	no data	CA$295.97k	geen gegevens
Graham Farrell	Investor Relations Officer	no data	geen gegevens	geen gegevens
Niels Tofting	Executive VP & MD of North American Operations	less than a year	CA$331.69k	geen gegevens
Robert Lazar	Executive VP of Professional Services & Customer Care	8yrs	CA$245.00k	geen gegevens
Vijit Coomara	Executive Vice President of Product Development	8yrs	CA$218.00k	geen gegevens

8.0yrs

Gemiddelde duur

Ervaren management: Het managementteam van VHI is doorgewinterd en ervaren (gemiddelde ambtstermijn van 8 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Daniel Matlow	President	8.2yrs	CA$836.36k	1.68% CA$ 9.9m
Francis Shen	Chairman of the Board	5.7yrs	CA$45.00k	8.23% CA$ 48.5m
Anthony Shen	Independent Director	3.8yrs	CA$45.00k	2.32% CA$ 13.7m
Stephen Garrington	Independent Director	8.2yrs	CA$45.00k	0.11% CA$ 676.2k
Roger Dent	Independent Director	10yrs	CA$50.00k	0.54% CA$ 3.2m
Barry Tissenbaum	Independent Director	8.2yrs	CA$55.00k	0.10% CA$ 597.3k

8.2yrs

Gemiddelde duur

67yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van VHI wordt beschouwd als ervaren (gemiddelde ambtstermijn 8.2 jaar).

Bedrijfsanalyse en status van financiële gegevens

Gegevens	Laatst bijgewerkt (UTC-tijd)
Bedrijfsanalyse	2025/01/02 02:52
Aandelenkoers aan het einde van de dag	2025/01/02 00:00
Inkomsten	2024/09/30
Jaarlijkse inkomsten	2023/12/31

Gegevensbronnen

De gegevens die gebruikt zijn in onze bedrijfsanalyse zijn afkomstig van S&P Global Market Intelligence LLC. De volgende gegevens worden gebruikt in ons analysemodel om dit rapport te genereren. De gegevens zijn genormaliseerd, waardoor er een vertraging kan optreden voordat de bron beschikbaar is.

Pakket	Gegevens	Tijdframe	Voorbeeld Amerikaanse bron ^*
Financiële gegevens bedrijf	10 jaar	Resultatenrekening Kasstroomoverzicht Balans	SEC-formulier 10-K SEC-formulier 10-Q
Consensus schattingen analisten	+3 jaar	Financiële prognoses Koersdoelen analisten	Onderzoeksrapporten van analisten Blue Matrix
Marktprijzen	30 jaar	Aandelenprijzen Dividenden, splitsingen en acties	ICE Marktgegevens SEC-formulier S-1
Eigendom	10 jaar	Top aandeelhouders Handel met voorkennis	SEC-formulier 4 SEC-formulier 13D
Beheer	10 jaar	Leiderschapsteam Raad van bestuur	SEC-formulier 10-K SEC-formulier DEF 14A
Belangrijkste ontwikkelingen	10 jaar	Bedrijfsaankondigingen	SEC-formulier 8-K

^* voorbeeld voor effecten uit de VS, voor niet-Amerikaanse effecten worden gelijkwaardige regelgevingsformulieren en bronnen gebruikt.

Tenzij anders vermeld zijn alle financiële gegevens gebaseerd op een jaarperiode, maar worden ze elk kwartaal bijgewerkt. Dit staat bekend als Trailing Twelve Month (TTM) of Last Twelve Month (LTM) gegevens. Lees hier meer.

Analysemodel en Snowflake

Details van het analysemodel dat is gebruikt om dit rapport te genereren, zijn beschikbaar op onze Github-pagina. We hebben ook handleidingen voor het gebruik van onze rapporten en tutorials op Youtube.

Leer meer over het team van wereldklasse dat het Simply Wall St-analysemodel heeft ontworpen en gebouwd.

Industrie en sector

Onze industrie- en sectormetrics worden elke 6 uur berekend door Simply Wall St, details van ons proces zijn beschikbaar op .

Bronnen van analisten

Vitalhub Corp. wordt gevolgd door 9 analisten. 7 van deze analisten hebben de schattingen van de omzet of winst ingediend die zijn gebruikt als input voor ons rapport. Inzendingen van analisten worden de hele dag door bijgewerkt.

Analist	Instelling
Gabriel Leung	Beacon Securities Limited
Douglas Taylor	Canaccord Genuity
Gavin Fairweather	Cormark Securities Inc.

Vitalhub Beheer

Beheer criteriumcontroles 3/4

Belangrijke informatie

Recente managementupdates

Insufficient new directors

Vitalhub Corp. Announces Executive Promotions

Chairman of the Board recently bought CA$1.5m worth of stock

Vitalhub Corp., Annual General Meeting, Jun 27, 2024

Vitalhub Corp. Announces Board Changes

Insufficient new directors

Recent updates

Vitalhub Corp. has filed a Follow-on Equity Offering in the amount of CAD 30.00007 million.

Consensus EPS estimates fall by 13%, revenue upgraded

Third quarter 2024 earnings: EPS misses analyst expectations

Vitalhub Corp. to Report Q3, 2024 Results on Nov 13, 2024

Price target increased by 7.8% to CA$10.96

Vitalhub Corp. (TSX:VHI) acquired Strata Health Solutions Inc for CAD 36.8 million.

Vitalhub Corp. (TSX:VHI) completed the acquisition of MedCurrent Corporation for CAD 33.9 million

Consensus EPS estimates fall by 33%, revenue upgraded

Vitalhub's (TSE:VHI) Performance Is Even Better Than Its Earnings Suggest

Price target increased by 13% to CA$9.29

Vitalhub Corp. (TSE:VHI) Soars 25% But It's A Story Of Risk Vs Reward

Second quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Vitalhub Corp. (TSX:VHI) agreed to acquire MedCurrent Corporation for CAD 33.9 million.

Vitalhub Corp. to Report Q2, 2024 Results on Aug 08, 2024

Consensus EPS estimates fall by 11%, revenue upgraded

First quarter 2024 earnings: EPS in line with analyst expectations despite revenue beat

Vitalhub Corp. to Report Q1, 2024 Results on May 09, 2024

Insufficient new directors

Vitalhub Corp. Announces Executive Promotions

Chairman of the Board recently bought CA$1.5m worth of stock

New minor risk - Shareholder dilution

Vitalhub Corp., Annual General Meeting, Jun 27, 2024

Vitalhub Corp. has completed a Follow-on Equity Offering in the amount of CAD 40.254 million.

Vitalhub Corp. has filed a Follow-on Equity Offering in the amount of CAD 35.004 million.

Price target increased by 8.5% to CA$6.92

Full year 2023 earnings: EPS misses analyst expectations

Vitalhub Corp. to Report Q4, 2023 Results on Mar 21, 2024

Price target increased by 11% to CA$6.04

Investor sentiment improves as stock rises 18%

After Leaping 27% Vitalhub Corp. (TSE:VHI) Shares Are Not Flying Under The Radar

Vitalhub Corp. (TSX:VHI) acquired Bookwise Solutions Limited.

If EPS Growth Is Important To You, Vitalhub (TSE:VHI) Presents An Opportunity

Vitalhub Corp.'s (TSE:VHI) P/E Is Still On The Mark Following 40% Share Price Bounce

Shareholders Will Be Pleased With The Quality of Vitalhub's (TSE:VHI) Earnings

Consensus EPS estimates increase by 44%

Investor sentiment improves as stock rises 20%

Price target increased by 8.5% to CA$5.33

Vitalhub Corp. Announces Board Changes

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

Vitalhub Corp. to Report Q3, 2023 Results on Nov 09, 2023

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Vitalhub Corp. to Report Q2, 2023 Results on Aug 10, 2023

First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Vitalhub Corp. to Report Q1, 2023 Results on May 12, 2023

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Vitalhub Corp. (TSX:VHI) acquired Coyote Software Corporation for CAD 2.37 million.

Is Vitalhub (TSE:VHI) A Risky Investment?

Insufficient new directors

Third quarter 2022 earnings: EPS misses analyst expectations

Vitalhub Corp. (TSX:VHI) acquired assets to maintain the business of Advanced Digital Innovation.

Vitalhub Corp. to Report Q3, 2022 Results on Nov 10, 2022

Second quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Vitalhub Corp. to Report Q2, 2022 Results on Aug 11, 2022

Insufficient new directors

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

Vitalhub Corp. to Report Q1, 2022 Results on May 12, 2022

Brokers Are Upgrading Their Views On Vitalhub Corp. (TSE:VHI) With These New Forecasts

Vitalhub Corp., Annual General Meeting, Jun 29, 2022

Full year 2021 earnings: EPS exceeds analyst expectations

Director recently bought CA$291k worth of stock

Third quarter 2021 earnings released: CA$0.016 loss per share (vs CA$0.039 loss in 3Q 2020)

Vitalhub Corp.(TSXV:VHI) dropped from S&P/TSX Venture Composite Index

Second quarter 2021 earnings released: CA$0.014 loss per share (vs CA$0.007 profit in 2Q 2020)

Are Investors Undervaluing Vitalhub Corp. (CVE:VHI) By 40%?

Here's Why Shareholders May Want To Be Cautious With Increasing Vitalhub Corp.'s (CVE:VHI) CEO Pay Packet

First quarter 2021 earnings released: CA$0.007 loss per share (vs CA$0.029 loss in 1Q 2020)

Vitalhub Corp. (TSXV:VHI) completed the acquisition of Assets of On-premises Acute (hospital) queue management business of Jayex Healthcare Limited (ASX:JHL).

Vitalhub Corp.'s (CVE:VHI) Intrinsic Value Is Potentially 48% Above Its Share Price

President exercised options to buy CA$216k worth of stock.